Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PATIENTLÅN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.4% 0.4%   Bankruptcy risk   3.5% 6.5% 3.4% 4.6% 6.9% 5.5% 16.1% 16.1%   Credit score (0-100)   55 38 54 44 34 40 11 11   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,252 1,909 2,003 1,554 404 820 0.0 0.0   EBITDA   425 1,316 1,237 527 -334 256 0.0 0.0   EBIT   329 1,109 1,065 288 -591 110 0.0 0.0   Pre-tax profit (PTP)   -58.2 541.9 487.4 -328.9 -1,109.4 -181.7 0.0 0.0   Net earnings   -58.2 554.5 380.1 -257.2 -865.3 -141.7 0.0 0.0   Pre-tax profit without non-rec. items   -58.2 542 487 -329 -1,109 -182 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -356 198 579 321 -544 -686 -972 -972   Interest-bearing liabilities   15,728 11,774 21,062 19,755 13,300 6,522 972 972   Balance sheet total (assets)   15,468 20,201 22,308 20,556 13,284 6,353 0.0 0.0   Net Debt   15,728 11,774 21,062 19,755 13,300 6,522 972 972     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,252 1,909 2,003 1,554 404 820 0.0 0.0   Gross profit growth   55.1% 52.5% 4.9% -22.4% -74.0% 102.8% -100.0% 0.0%   Employees   3 2 2 3 2 1 0 0   Employee growth %   50.0% -33.3% 0.0% 50.0% -33.3% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   15,468 20,201 22,308 20,556 13,284 6,353 0 0   Balance sheet change%   47.7% 30.6% 10.4% -7.9% -35.4% -52.2% -100.0% 0.0%   Added value   424.8 1,316.5 1,237.1 527.0 -352.0 256.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   494 -408 -40 -362 -471 -285 -46 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.3% 58.1% 53.2% 18.5% -146.3% 13.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.5% 6.2% 5.0% 1.3% -3.4% 1.1% 0.0% 0.0%   ROI %   2.5% 8.0% 6.3% 1.4% -3.5% 1.1% 0.0% 0.0%   ROE %   -0.4% 7.1% 97.8% -57.1% -12.7% -1.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   24.1% 26.3% 33.1% 34.7% 36.1% 75.3% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   3,702.5% 894.4% 1,702.6% 3,748.6% -3,982.2% 2,547.3% 0.0% 0.0%   Gearing %   -4,417.8% 5,932.0% 3,640.2% 6,145.8% -2,445.4% -951.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 4.1% 3.5% 3.0% 3.1% 2.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.0 1.0 1.0 1.0 0.9 0.0 0.0   Current Ratio   0.9 1.0 1.0 1.0 0.9 0.9 0.0 0.0   Cash and cash equivalent   0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -976.2 -181.2 123.1 -70.0 -689.8 -690.2 -485.8 -485.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   142 658 619 176 -176 256 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   142 658 619 176 -167 256 0 0   EBIT / employee   110 554 533 96 -296 110 0 0   Net earnings / employee   -19 277 190 -86 -433 -142 0 0